Neoadjuvant chemotherapy for advanced ovarian cancer was initially administered as an alternative treatment for patients not suitable for primary debulking surgery (PDS) because of unresectable ...

Primary debulking surgery for advanced epithelial ovarian cancer with isolated enlarged para-aortic lymph node by robotic transumbilical single port approach. Low pressure laparoscopic procedure ...

Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

The chance that debulking surgery will be successful is greater in peritoneal cancer than in ovarian cancer, but the overall survival rate is worse for peritoneal cancer. No screening test has ...

AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients ... application in predicting debulking outcomes. Despite these challenges ...

Opportunistic salpingectomy (OS) during any suitable abdominal surgery is effective for reducing the incidence of ovari ...